TrialBMJ open2017

Protocol for the TIDAL Melanoma Study: topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases-a phase II, single centre, randomised, pilot study.

Tavis Read et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.